2(1H)-Pyrimidinone, 1-(2-deoxy-b-D-erythro-pentofuranosyl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)
2(1H)-Pyrimidinone, 1-(2-deoxy-b-D-erythro-pentofuranosyl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)(109389-25-5)
- Name: 2(1H)-Pyrimidinone, 1-(2-deoxy-b-D-erythro-pentofuranosyl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)
- Synonyms:2(1H)-Pyrimidinone, 1-(2-deoxy-b-D-erythro-pentofuranosyl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)
- Molecular Formula:C12H15 N5 O4
- Molecular Weight:293.282
- CAS Registry Number:109389-25-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.109389-25-5 1-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)pyrimidin-2(1H)-one
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.109389-25-5 1-[4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-5-methyl-4-(1,2,4-triazol-1-yl)-2-pyrimidinone
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.109389-25-5 1-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)pyrimidin-2(1H)-one
Assay:97% Appearance:Contact us for details Package:According to the requirements of customer Storage:Store in a tightly closed container in a cool and dry place. Transportation:Door to door by Fedex/DHL or by air Application:Research & Development
Min. Order:1Milligram
Supplier:NewCan Biotech Limited [
China (Mainland)]
Other Product
- 102782-97-8/EPOXYPROPOXYPROPYL TERMINATED POLYDIMETHYLSILOXANE
- 32883-76-4/methyl (2Z)-[5-hydroxy-4-(3-iodophenyl)-3-oxofuran-2(3H)-ylidene](3-iodophenyl)ethanoate
- 18800-78-7/BOC-GLN-OSU
- 94854-42-9/5,12-Naphthacenedione,7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-methyl-1,3-dioxolan-2-yl)-7-(4-morpholinyl)-,(7R,9R)-rel-
- 72083-53-5/ethyl (4-methyl-4H-pyrrolo[3,2-d][1,3]thiazol-2-yl)carbamate
- 26028-63-7/5-(3-CHLOROPHENYL)-4-ETHYL-4H-1,2,4-TRIAZOLE-3-THIOL
- 24548-16-1/3'H-Cycloprop[2,3]androst-2-ene(8CI,9CI)
- 6703-46-4/1H-Imidazo[4,5-c]pyridine,1-b-D-ribofuranosyl-
- 54012-87-2/2,3,10,11-tetrahydro-1H,7H-cyclopenta[6,7][1,4]diazepino[3,2,1-ij]quinolin-8(9H)-one
- 58933-26-9/9-(β-D-Glucopyranosyloxy)-11-hydroxy-2-methoxy-12H-benzo[a]xanthen-12-one
- 26982-08-1/Poly(oxy-1,2-ethanediyl),a-hydro-w-hydroxy-, potassium salt (1:?)
- 94110-11-9/7-Hydroxy-8-((4-(phenylazo)phenyl)azo)naphthalene-1,3-disulphonic acid, compound with N,N-di(o-tolyl)guanidine
- 77272-10-7/macrocortin
- 774-18-5/o-(trifluoromethyl)phenethylamine
- 99751-56-1/Calcitonin (human clonepSM9101 reduced) (9CI)
- 4873-52-3/N-[4-(dimethylamino)benzyl]-N-(1,1-dioxidotetrahydrothiophen-3-yl)-2-(3-methylphenoxy)acetamide
- 6750-16-9/N-[(3-bromo-6-oxo-1-cyclohexa-2,4-dienylidene)methyl]-5-(4-fluorophenyl)-2H-pyrazole-3-carbohydrazide
- 98219-46-6/Naphtha (petroleum),light steam-cracked, debenzenized, thermally treated
- 29682-41-5/1,4-DICHLORO-2-IODOBENZENE
- 109389-25-5/2(1H)-Pyrimidinone, 1-(2-deoxy-b-D-erythro-pentofuranosyl)-5-methyl-4-(1H-1,2,4-triazol-1-yl)
- 6275-92-9/4-methylpiperidine-1-carbodithioic acid - 4-methylpiperidine (1:1)
- 21485-22-3/Molybdenum,pentacarbonyl(tributyl phosphite-P)-, (OC-6-22)- (9CI)
- 796-46-3/4-{(E)-2-[4-(dimethylamino)phenyl]ethenyl}quinolin-8-ol
- 78593-83-6/4-(4,5,6,7-tetrahydro-2H-4,7-methanoisoindol-2-yl)benzenesulfonamide
- 1934-25-4/CIACIDYELLOW13
- 7465-52-3/dimethyl 4,7-bis(3-methoxy-3-oxopropyl)-4,7-dinitrodecanedioate
- 68479-12-9/2-Propen-1-ol, polymerwith ethenylbenzene, hydrogen butanedioate, esters with coco fatty acids
- 25260-34-8/[2-(pyridin-4-yl)-1,3-dioxolan-2-yl]methyl formate
- 201747-29-7/3-{[(E)-(4,9-dimethoxy-5-oxo-5H-furo[3,2-g]chromen-7-yl)methylidene]amino}-1-ethyl-2-thioxoimidazolidin-4-one
- 93778-73-5/Bis(beta-hydroxy-alpha-methylphenethyl)methylammonium (R-(R*,R*))-tartrate